Table 3 Association between clinicopathological parameters and the crude proportion of patients who developed peritoneal metastases (PM).

From: The measured distance between tumor cells and the peritoneal surface predicts the risk of peritoneal metastases and offers an objective means to differentiate between pT3 and pT4a colon cancer

 

No PM N (%)

PM N (%)

p value

Tumor & histopathological characteristics

Tumor location

  Right sided

58 (73.4)

21 (26.6)

0.079

  Left sided

89 (84.0)

17 (16.0)

Type and differentiation

  Well/moderately differentiated adenocarcinoma

112 (83.0)

23 (17.0)

0.122

  Poorly differentiated adenocarcinoma

17 (73.9)

6 (26.1)

  Mucinous carcinoma

16 (80.0)

4 (20.0)

  Signet ring cell carcinoma

6 (54.5)

5 (45.5)

Tumor border configuration

  Pushing

49 (89.1)

6 (10.9)

0.043

  Infiltrating

102 (76.1)

32 (23.9)

Tumor budding

  Low budding (Bd1)

57 (86.4)

9 (13.6)

0.261

  Intermediate budding (Bd2)

21 (75.0)

7 (25.0)

  High budding (Bd3)

73 (76.8)

22 (23.2)

Tumor-stroma ratio

  Stroma-low (≤50% stroma)

66 (78.6)

18 (21.4)

0.685

  Stroma-high (>50% stroma)

85 (81.0)

20 (19.0)

  Venous invasion

77 (77.0)

23 (23.0)

0.293

  Lymphatic invasion

55 (70.5)

23 (29.5)

0.007

  Perineural invasion

75 (72.8)

28 (27.2)

0.008

Lymph node status

  pN0

42 (84.0)

8 (16.0)0

0.118

  pN1 (1–3 positive nodes)

57 (85.1)

10 (14.9)

  pN2 (4+ positive nodes)

52 (72.2)

20 (27.8)

  Tumor deposits

45 (83.3)

9 (16.7)

0.456

  Irradical resection (R1)

19 (76.0)

6 (24.0)

0.602

  pT4b

28 (80.0)

7 (20.0)

0.986

Distance from tumor to free peritoneal surface in micrometers (um)

  Full peritoneal penetration of tumor cells onto the peritoneal surface

67 (75.3)

22 (24.7)

0.038

  Shortest distance to free peritoneal surface 0–99 µm

24 (70.6)

10 (29.4)

  Shortest distance to free peritoneal surface 100–999 µm

31 (93.9)

2 (6.1) 

  Shortest distance to free peritoneal surface ≥1000 µm

29 (87.9)

4 (12.1)

  1. Bold values indicate a statistical significant difference (p < 0.05).
  2. Bd budding, pN lymph node status.